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Abstract  
Preterm brain injury, occurring in approximately 30% of infants born <32 weeks gestational 
age, is associated with an increased risk of neurodevelopmental disorders, such as autism 
spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD). The mechanism 
of grey matter injury in preterm born children is unclear and likely to be multifactorial, however 
inflammation, a high predictor of poor outcome in preterm infants, has been associated with 
disrupted interneuron maturation in a number of animal models. Interneurons are important 
for regulating normal brain development, and disruption in interneuron development, and the 
downstream effects of this, has been implicated in the aetiology of neurodevelopmental 
disorders. Here we utilise post-mortem tissue from human preterm cases with) or without 
diffuse white matter injury (WMI; PMA range: 23+2 to 28+1 for non-WMI group, 26+6 to 30+0 for 
WMI group, p=0.002), and a model of inflammation-induced preterm diffuse white matter injury 
(i.p. IL-1β, b.d., 10µg/kg/injection in male CD1 mice from P1-5). Data from human preterm 
infants show deficits in interneuron numbers in the cortex and delayed development of 
neuronal arbours at this early stage of development. In the mouse, significant reduction in the 
number of parvalbumin positive interneurons was observed from postnatal day (P) 10. This 
decrease in parvalbumin neuron number was largely rectified by P40, though there was a 
significantly smaller number of parvalbumin positive cells associated with perineuronal nets in 
the upper cortical layers. Together, these data suggest that inflammation in the preterm brain 
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may be a contributor to injury of specific interneuron in the cortical grey matter. This may 
represent a potential target for postnatal therapy to reduce the incidence and/or severity of 
neurodevelopmental disorders in preterm infants. 
Key words 
Parvalbumin, perineuronal nets, neuroinflammation, mouse, human  
Introduction  
While preterm birth has a multi-factorial aetiology, it is widely recognised as being precipitated 
by pro-inflammatory events (reviewed by Hagberg et al. 2015), and these vulnerable infants 
are at risk of further exposure to inflammation and infection. As such, in preterm born infants 
the severity and duration of inflammation highly correlates with long term outcome (Kuban et 
al. 2015). Inflammation is also a risk factor in the development of neurodevelopmental 
disorders (Hagberg et al. 2012, Jiang et al. 2018), such as autism spectrum disorder (ASD), 
attention deficit hyperactivity disorder (ADHD), childhood epilepsy and disorders of learning, 
cognition and emotional development. Given the associations, it is possibly unsurprising that 
up to 30% of preterm born infants are diagnosed with a neurodevelopmental disorders in 
childhood (Marlow et al. 2005, Wood et al. 2005, Johnson et al. 2010, Franz et al. 2018). 
Neurodevelopmental disorders have a substantial effect on the quality of life of affected 
individuals and their families, but we have limited options to improve the brain health of these 
infants. The development of therapies is hampered by the fact that the neuropathology of 
developmental disorders is as mixed as the diagnosis, varying both between and within 
specific clusters of disorders.  
 
Specifically in preterm born infants, patterns of white matter injury, and increasingly of a grey 
matter injury, are recognised and associated with poor outcome. In contemporary cohorts of 
preterm infants, white matter injury includes periventricular leukomalacia in the most severe 
cases and more commonly diffuse white matter injury (Counsell et al. 2003, Back et al. 2007, 
Buser et al. 2010). The scale of white matter injury correlates with the severity of the outcome 
for preterm born infants (Counsell et al. 2008, Keunen et al. 2017, Tusor et al. 2017). Diffuse 
white matter injury has been successfully modelled in mice and sheep by re-capitulating the 
exposure to early-life inflammation seen in preterm born infants (Mallard et al. 2003, Stolp et 
al. 2005, Dean et al. 2009, Favrais et al. 2011), though chronic hypoxia can result in similar 
pathology (Back et al. 2006), supporting a multi-factorial aetiology. Improvements in imaging 
modalities have made it possible to study the ultrastructure of the grey matter. Concomitantly 
there has been a reduction in the most severe forms of white matter injury allowing the nature 
of subtle grey matter deficits to be probed in more detail. The microstructural pathology in the 
grey matter of preterm infants is still an on-going study (Ajayi-Obe et al. 2000, Boardman et 
al. 2006, Ball et al. 2013, Batalle et al. 2019) but it is clearly linked with the later development 
of cognitive disorders (Kersbergen et al. 2016, Lean et al. 2017). However, inflammation, 
synaptic dysfunction and altered gamma-aminobutyric acid (GABA) signalling are frequently 
identified as underlying causes and mechanisms of injury in neurodevelopmental disorders 
(Pardo and Eberhart 2007, Pinto et al. 2010, Deidda et al. 2014, Coelewij and Curtis 2018, 
Dark et al. 2018). This suggests that synaptic dysfunction and altered GABA signalling are 
valid candidates to mediate the neurodevelopmental disorders associated with 
encephalopathy of prematurity.  
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Interneurons make up approximately 20-30% of cells within the cortex (slightly higher in 
primates than mice; Jones 2009), and provide inhibitory balance for the excitatory pyramidal 
neurons by connecting cortical layers and cortical regions via interactions with glia, the 
vasculature and other neurons (Cossart 2011, Marin 2012, Marin 2013, Barber et al. 2018). 
Interneurons are primarily born within the medial and lateral ganglionic eminence during 
embryonic development and migrate to the cortex during the early postnatal period, where 
they mature over the first few weeks of life in mice (Cossart 2011), equivalent to early 
childhood in humans. This maturation process includes differential expression of subtype 
markers (see below), maturation of dendritic arbours and synapsis, as well as changes in 
synaptic activity, and contacts, and transient networks (Butt et al. 2005, Cossart 2011, 
Marques-Smith et al. 2016, Butt et al. 2017). There is a complex array of interneuron subtypes 
based on their morphological, electrophysiological and molecular signatures (Kelsom and Lu 
2013). Major populations of interneurons in the cortex include those immunopositive for 
somatostatin (SST), calbindin (CalB), calretinin (CalR) and parvalbumin (PV). Changes in 
interneurons is termed an interneuronopathy and deficits in each of these cellular subtypes 
have been associated with neurodevelopmental disorders (Marin 2012), including those 
prevalent in preterm born children. There is currently little known about the effect of 
prematurity on cortical interneurons, although a recent study by Panda and colleagues (2018) 
has shown a general decrease in GABAergic (glutamate decarboxylase, GAD, positive) 
interneurons in the cortex, primarily driven by a decrease in parvalbumin positive interneurons 
in the upper (layers II-IV), and to a lesser degree, lower (layers V & VI) cortex (Panda et al. 
2018). However, this study focused on the effect of early or later prematurity and did not 
specifically study cases of encephalopathy of prematurity compared with controls. Changes 
in parvalbumin-positive interneurons in particular are commonly reported in studies of patients 
with neurodevelopmental disorders, or in associated animal models (Kataoka et al. 2010, 
Gandal et al. 2012, Bitanihirwe and Woo 2014, Barnes et al. 2015, Filice et al. 2016, Hashemi 
et al. 2018, Vogt et al. 2018). Parvalbumin knockout mice have ASD-like behavioural 
symptoms (Wohr et al. 2015). Additionally, knockout of metabotropic glutamate receptors 
(mGluR5) in parvalbumin interneurons results in specific memory deficits, altered sensory 
motor gating and increased compulsive-like behaviours (Barnes et al. 2015). Similarly, 
maternal immune activation, a common experimental model for ASD, reduces parvalbumin 
inhibitory activity on pyramidal neurons, resulting in defects in attentional shifting (Canetta et 
al. 2016). Interneurons, including parvalbumin-positive interneurons, have a specialised area 
of extracellular matrix (chondroitin sulphate proteoglycans) surrounding them, called a 
perineuronal net. It has been shown in the past years that this net forms and enlarges during 
development, representing a marker of a functionally mature neuron. The perineuronal net 
plays a role in regulating plasticity and deficits are associated with epilepsy induced plasticity 
(Galtrey and Fawcett 2007). 
 
Here we aim to assess whether there is a subtype specific disruption in interneuron maturation 
in our population of preterm infants with diffuse white matter injury compared with age-
matched controls. Further to this, in mice exposed to IL-1β-induced inflammation, which 
produces diffuse white matter injury (Favrais et al. 2011, Krishnan et al. 2017), we will assess 
the long-term trajectory of interneuron development, and the consequences for wider cortical 
maturation.  
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Methods 
Human post mortem tissue 
Written informed parental consent was acquired according to the National Health Services 
(NHS) UK guidelines and study ethics were obtained from the National Research Ethics 
Services (West London), UK (ethics number: 07/H0707/139; Post-mortem Magnetic Imaging 
Study of the Developing Brain). Thirteen extremely preterm post-mortem brains (<30 weeks 
gestational age, 1 female/12 male) of vaginally delivered neonates were used in this study 
and obtained from the Perinatal Pathology Department, Imperial Health Care Trust, London 
UK. The primary cause of death for each case was assessed by a pathologist. Brain tissue 
blocks from these cases had a post-menstrual age (PMA) range from 23+2 to 30+0 weeks, 
calculated by GA (at birth), plus age at death (PMA range for each cohort: 23+2 to 28+1 for non-
WMI cases, 26+6 to 30+0 for WMI cases, p=0.002). The details of each case are summarised 
in Table 1. Amniotic fluid infections were identified in most cases, however no cases had 
identifiable vascular thrombosis or leptomeningitis. From post-mortem examination, brains 
were assessed macroscopically and microscopically. Seven cases showed no significant brain 
pathology, these were used as non-neuropathologic controls (no WMI cases). Six brains had 
evidence of diffuse (non-cystic) white matter injury (WMI cases) including white matter gliosis 
and focal lesions. 
  
As previously reported (Supramaniam et al. 2013, Vontell et al. 2013) after post-mortem, 
whole brains were fixed with 4% formalin for 5 – 7 weeks, depending on size. The whole brains 
were sliced by a pathologist, and tissue blocks were processed on a Bright Tissue Processor 
(Bright Instrument Co. Ltd.). Paraffin-embedded tissue blocks of the frontal lobe at the level of 
the caudate (i.e. anterior to Ammon’s Horn) were sectioned at 6µm using a Leica RM2245 
microtome (Leica Microsystems Ltd.). 
Animal model 
All animal procedures were approved by the UK Home Office according to the regulations in 
the Animal (Scientific Procedures) Act (2012), and the King’s College London (KCL) Animal 
Welfare and Ethical Review Board (AWERB; PPL 70/8376). Inflammation-associated brain 
injury of the preterm born infant was modelled in mice by exposing them to systemic 
inflammation from postnatal day 1 (P1) through to P5; P0 is the day of birth, as previously 
reported (Favrais et al. 2011). P1-P5 is approximately equivalent to the period of 23-32 weeks 
gestation for brain development in the human pregnancy, based on a mixture of myelination 
and cortical development processes (Clancy et al. 2001, Clancy et al. 2007, Semple et al. 
2013). Pregnant CD-1 mice were purchased from Charles Rivers, and transferred to the KCL 
Biological Services Unit (BSU) at embryonic day (E) 16 of pregnancy. Animals were housed 
separately in individually ventilated cages with food and water available ad libitum, in a 
temperature controlled environment with a 12 hour light-dark cycle. This injection paradigm 
only produces consistent and reproducible diffuse white matter injury in male mice (Favrais et 
al. 2011), compared with female mice. Therefore, following birth, female pups were culled by 
cervical dislocation, and male pups were randomly divided into litters for saline or IL-1β 
treatment (typically numbering 4-7 pups per ‘new’ litter). Each pup received a 5μl 
intraperitoneal (i.p.) injection twice daily from P1 to P4, and a final injection in the morning at 
P5 (Favrais et al. 2011). IL-1β (R&D Systems) was diluted in saline to a working concentration 
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of 8ng/µl (for a final dose of 10µg/kg/injection). Animals remained housed in litter groups until 
weaning (P21), when they were group housed (3-4/cage). At P5 (6 hours post final injection), 
P10 (approximate time of six layered cortex formation), P40 (when interneuron markers are 
mature), and P60 (early adulthood) randomly selected pups from each litter were killed by 
terminal anaesthesia (i.p. pentobarbitone overdose) and perfused with saline followed by cold 
4% paraformaldehyde. The brain was dissected out of the skull and immersion fixed in Bouin’s 
solution (Sigma). Fixed tissue was washed and dehydrated through graded alcohol 
(progressing from 50-100%) and embedded in paraffin wax (Sigma, UK). Coronal 6μm thick 
consecutive sections were cut and placed on microscope slides, with three sections at an 
interval of approximately 250μm per slide. 
Immunohistochemistry & Microscopy 
As previously reported (Vontell et al. 2013) post mortem human sections underwent routine 
paraffin removal and rehydration, then were placed in 3% hydrogen peroxide to quench 
endogenous peroxidase activity, and immersed in preheated 10mM citric acid with 0.1% 
Tween-20 (VWR International Ltd.) for 30 min and cooled at room temperature for 20 min. 
Sections were blocked with 5% normal goat or horse serum (as appropriate based on the 
secondary antibody host species) and primary antibodies were incubated overnight at 4°C; 
concentrations below. The next day, biotinylated secondary antibodies (1:200, Vector 
Laboratories) goat anti-rabbit, goat anti-rat, or horse anti-mouse were incubated for 1h at room 
temperature, then with avidin-biotin complex (ABC, 1:200, Vector Laboratories, UK) for 1h. 
The reactions were visualised with 3,3’-diamino-benzidine (DAB; Sigma-Aldrich Company) for 
10 min. Sections were then dehydrated, cleared in xylene and cover-slipped. Primary 
antibodies used to identify all neurons in the developing human cortex was mouse anti-
HuC/HuD (1:500, Life Technologies) and interneuron markers; mouse anti-Calretinin (CalR; 
1:100, Millipore), mouse anti-Calbindin D-28 (CalB; 1:100, Sigma), rabbit anti-Parvalbumin 
(PV; 1:500, Abcam), rat anti-Somatostatin (SST; 1:50, Abcam), rabbit polyclonal Neuropeptide 
Y (NPY; 1:5000, Abcam). Routine H&E staining was also performed on this cohort of brain 
samples to assess for gross neuropathologies. 
 
Mouse tissue was processed as described above and stained as previously reported (Stolp et 
al. 2011). Mouse anti-CTIP2 (1:400; Abcam) was used to identify neurons in the developing 
cortical plate in the mouse (Stolp et al. 2011, Garcez et al. 2018). Interneuron populations 
were stained with one of rabbit anti-Parvalbumin (PV, 1:200, Abcam), rabbit anti-Calretinin 
(CalR, 1:200, Swant), rat anti-Somatostatin (SST, 1:100, Abcam), rabbit anti-Neuropeptide Y 
(NPY, 1:100, Abcam), mouse anti-Calbindin (CalB, 1:100, Sigma), mouse anti-Reelin (1:500, 
Calbiochem), rabbit anti-Vasoactive Intestinal Peptide (VIP, 1:100, Abcam). Perineuronal nets 
were identified using biotinylated Wisteria Floribunda Lectin (WFL, 1:200, Vector). Sections 
were incubated in the appropriate biotinylated or fluorescently-tagged secondary antibody: 
biotinylated goat anti-rabbit or mouse (1:200, Vector); donkey anti-mouse-488; donkey anti-
rabbit-488/546 (1:400, Invitrogen) or streptavidin-488 (1:400, Invitrogen). All antibodies and 
lectins were diluted in 1% donkey serum in phosphate-buffered saline with 1% tween-20. 
Sections with fluorescent secondaries were incubated with DAPI for 5 minutes (4’,6-diamidino-
2-phenylindole, 1:1000, SigmaAldrich) and mounted with ProlongGold (ThermoFisher 
Scientific).  
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A subset of brains were processed for Golgi staining using the FD Rapid GolgiStain Kit (FD 
Neurotechnologies Inc.), following the manufacturer's instructions.  Briefly, brain tissue was 
washed in dH2O immediately following collection and then incubated in impregnation solution 
for 2 weeks. After this period, the samples were incubated in Solution C for 3 days before 
tissue sections were cut with a Vibratome (Leica) at 100μm thickness, mounted in slides and 
dehydrated through ethanol and xylene before mounting with DPX (Sigma).  
Image Analysis and Statistics 
Human tissue sections were visualised with bright-field microscopy, using a light microscope 
(Leica DM6000B, Leica Microsystems Ltd.), CCD colour video camera (Leica CTR6000, 
Leica, UK), equipped with a motorised stage for automated sampling (MicroBrightfield Inc.). 
Cell number was assessed using optical fractionator stereological software (Stereo 
Investigator v8.27, MicroBrightfield Inc.). Contours were drawn around the frontal cortex 
magnified by a 5x objective (0.0426mm2), with an average area for each contour of 1mm2. 
Counting was performed at the magnification provided by the 40x objective, from multiple 
counting sites throughout the contour, to allow unbiased sampling of the frontal cortex and an 
estimate of cell density. The number of counting sites was for varied for each cell type, due to 
differences in density (determined from preliminary assessments of cell number), overall an 
average of 35-45 counting sites were used for each contour (Vontell et al. 2013, Vontell et al. 
2015). Three contours were assessed for each brain region of interest (cortex and subcortical 
white matter, therefore, approx. 3mm2 assessed in total for each), and averaged to produce 
the estimated cell density for each region. Neurite lengths were assessed in positively stained 
somatostatin and neuropeptide Y neurons from images obtained with a x40 objective. An 
average of seven cells were assessed per case, using ImageJ software (Schneider et al. 
2012). 
 
Mouse tissue sections were imaged with a Leica SP5 confocal microscope (P5, P10 and P40 
fluorescently stained mouse tissue) or Leica DM4000 upright microscope (P40 mouse tissue). 
For cell counts, upper (II-IV) and lower (V, VI) layer layers were delineated as a region of 
interest for each image, and the immunoreactive cells counted manually, by a blinded 
observer, using the ImageJ cell counter tool. For the parvalbumin/perineuronal net counts, 
multiple markers were used so that single labelled and double labelled neurons could be 
counted together in a single region of interest. Images were taken from the area of the 
somatosensory cortex identified by the presence of the barrel cortex, and measurements were 
averaged from both the medial (M1) and lateral (S1BF) cortex (Paxinos and Franklin 2012), 
from three sections per brain. Therefore, data was averaged from 3-6 images per brain (tissue 
was excluded if it was damaged or where the staining had excessively high background or 
was non-specific), and from 3-6 brains per treatment and age (P5: n=3-6 both groups; P10: 
n=5 saline, n=6 IL-1β; P40: n=3 saline, n=5 IL-1β).  
 
Cell counts are presented as mean ± standard deviation (SD). Statistical analysis was 
performed using Prism 7 (GraphPad). Post-mortem human samples were analysed with an 
unpaired t-test. Grouped data from P5 tissue was analysed using a two-way ANOVA for 
treatment and cell population, with post-hoc analysis performed with Sidak’s multiple 
comparison test. For P10 and P40 data, grouped data from each cell population was analysed 
using a two-way ANOVA for treatment and layer, with post-hoc analysis performed with 
Sidak’s multiple comparison test. A p-value <0.05 was considered statistically significant.  
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Golgi stained neurons, with consistent stain impregnation and isolation from neighbouring 
stained cells, were imaged with a Leica DM6000B microscope for analysis. Stacked images 
in the z-axis were obtained at x40 magnification, with a 1µm interval. Dendritic branching and 
intersections were quantified and analysed by Sholl analysis (Gutierrez and Davies 2007), 
using ImageJ image processing programme. Image stacks were compressed in one 2D image 
and the centre of the soma was marked for reference. Concentric circles, with radii increasing 
by 9.06µm (50 pixels) per circle, were set from the soma centre. Multiple neurons (10-15 from 
multiple slices across the brain) were analysed from 3 brains per treatment, and results are 
presented as the average number (± SD) of dendritic intersections per concentric circle, for 
each treatment group. Sholl profiles were statistically compared using a 2-way ANOVA for 
treatment and distance from soma. 
 
For spine analysis, dendrites were isolated in images of neuronal cells collected for Sholl 
analysis. Dendrites chosen were of different lengths, with a substantial portion in the plane of 
focus, and were representative of spine density and morphology of unselected dendrites. 
Spine density of selected dendrites was analysed using Image-Pro Premier image analysis 
software (MediaCybernectics). Data was blinded and images were categorised as having a 
high or low synaptic frequency (41 from saline treated brains, 57 from IL-1β treated) based on 
the number of synaptic protrusions along the length of the dendrite, and the spaces, if any, 
between the protrusions (Smrt and Zhao 2010, Phillips and Pozzo-Miller 2015). This 
categorical data was statistically compared using the Fisher exact test, with a p-value <0.05 
considered statistically significant. 
Results 
Preterm born infants with diffuse white matter injury had reduced number of calretinin 
interneurons in the cortex, and altered arborisation of other interneuron populations 
Stereological assessment of cell number in the frontal cortex of the developing human brain 
showed no change in the total number of neurons, identified by HuC/HuD immunoreactivity, 
with 53,104 ± 11,009 immunopositive cells/mm2 found in the control brains (n=5), and 52,120 
± 6,327 cells/mm2 in the cortex of the white matter injury cases (n=4). In contrast, there was a 
significant decrease in the cortical calretinin immunopositive cells in the white matter injury 
cases, compared with preterm infants without white matter injury (from 1,084 ± 96 cells/mm2 
to 663 ± 327 cells/mm2, p=0.043, Figure 1A-D). Calbindin and parvalbumin positive cells were 
observed in low numbers in both cases, insufficient for determining statistical significant 
changes. Somatostatin and neuropeptide Y immunopositive interneurons also occurred much 
less frequently than calretinin positive cells and were not found in the cortex at this stage of 
development. However, the cells immunopositive for these markers were found in the 
subcortical white matter, and these were analysed for neurite length and branching. There 
were no statistical differences in the number of cells in either interneuron (SST or NPY) 
subpopulation between preterm infants with or without white matter injury (n=5 for both). The 
branching of immunopositive cells was assessed with a modified Sholl Analysis, and there 
was a significant decrease in the arborisation of neurons in both of these interneuron classes. 
Somatostatin cells in white matter injury cases had shorter leading neurite length (33.2 ± 
8.7µm, n=6, compared with 56.7 ± 8.5 µm in the no WMI cases, n=6; p<0.001) and fewer 
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branches (7.4 ± 1.4 compared with 4.6 ± 0.7, p=0.001). Neuropeptide Y immunopositive 
neurons also had shorter neurites (51.5 ± 5.2 µm compared with 72.6 ± 13.7 µm in no WMI 
group, n=5-6; p=0.01) and fewer branches (5.3 ± 0.85 WMI, compared with 8.1 ± 1.9, p=0.009) 
in white matter injury cases (Figure 1E, F). 
 
The developmental trajectory of a number of interneuron populations is disturbed in a 
mouse model of preterm birth 
In mice with IL-1β-induced inflammation, at the end of the inflammatory exposure (P5), there 
was no gross alteration in the cortical layering (Figure 2A, DAPI) or cell density. In addition, 
no statistically significant change in CTIP2 immunoreactive neuron number per cortical area 
was observed (saline: 204.3 ± 37.4 cells, IL-1β: 162.7 ± 29.8 cells, p<0.086, Figure 2B), 
suggesting no overall change in the development of the early cortical neurons with injury. 
There was a significant decrease in the number of reelin positive (saline: 64.2 ± 5.1 cells, IL-
1β: 51.7 ± 5.7 cells, p=0.047) and calretinin positive (saline: 55.7 ± 9.7 cells, IL-1β: 31.3 ± 12.6 
cells, p<0.001) neurons in the IL-1β treated animals compared with the saline-treated control 
(Figure 2C). In comparison to these reelin and calretinin positive cells other interneuron 
populations were present in a much lower number (Figure 2A, C), as would be expected at 
this early stage of brain development, as the majority of interneuron markers don’t fully 
develop until the second or third postnatal week in the mouse (Cossart 2011). In general, at 
this stage of development, the interneuron populations were present in higher numbers in the 
lower cortical layers (layer V and VI) than in the upper layers (II, III & IV). Specific analysis of 
interneuron populations (PV, CalB, SST, NPY) in the upper layers showed no difference 
between treatment groups (Figure 2D). In the lower layers, two-way ANOVA analysis showed 
a significant treatment effect (p<0.043), reflecting a general increase in the same interneuron 
populations in the IL-1β group. However, no significant difference was found for individual 
populations following correction for multiple comparisons.  
 
At P10 (Figure 3), the somatostatin, neuropeptide Y, calretinin and calbindin populations were 
present in greater, though still relatively low, numbers, and there was no significant difference 
in their presence, or distribution through the cortex between the saline and IL-1β treated 
groups. Parvalbumin-positive cells were found in significantly greater numbers in layer IV, V 
and VI (p=0.005). There was an overall decrease in the number of parvalbumin-positive 
neurons (p<0.014), with no significant layer effect (Figure 3B).  
Parvalbumin interneurons show long-term disruption in neuronal number, arborisation 
and association with perineuronal nets 
To determine whether perturbations in parvalbumin number present at P10 in mice following 
IL-1β-induced inflammation persisted beyond this early developing period, the number of 
these neurons was assessed at a later stage of development. At P40, there was a trend 
towards a decrease in parvalbumin cells in the upper layers of the cortex, but not the lower 
layers (Figure 4A&B). The maturation state of parvalbumin interneurons was assessed by the 
presence of perineuronal nets, which start to form in a loose association with the parvalbumin 
neurons in the barrel cortex from P10 in the mouse (Figure 4A). Clear association of the nets 
with parvalbumin positive interneurons is visible by P40, which mature further as development 
continues (P60; Figure 4A, Ueno et al., 2017). When explored in more detail a statistically 
significant decrease in parvalbumin positive neurons that had fully formed perineuronal nets 
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(17.6 ± 0.2 cells/mm2 in saline, 15.1 ± 0.5 cells/mm2 in IL-1β, p=0.008) was seen specifically 
in the upper layer of the IL-1β treated animals (Figure 4C). At this age, there was a relatively 
high proportion of parvalbumin neurons without perineuronal nets (25% in saline), but there 
was no change in this subpopulation of neurons with treatment (32% in IL-1β group, p=0.8, 
Figure 4C). Likewise, in brains from both saline and IL-1β treated animals, a small number of 
perineuronal nets were observed without PV staining (1.5 ± 0.3 cells/mm2 in saline, 1.2 ± 0.2 
cells/mm2 in IL-1β), but the proportions were very low and there was no significant difference 
between groups. In comparison with these small but significant changes in parvalbumin 
interneurons, there remained no significant difference in the number of either neuropeptide Y, 
Calretinin or VIP positive neurons in the cortex between saline and IL-1β treated animals 
(Figure 5A-C). 
Long-term changes in arborisation and spine density are broadly observed in areas 
of the cortex with disrupted parvalbumin interneuron development 
Golgi staining was performed to visualise the individual neurons within the cortex, to allow 
Sholl and spine analysis to be performed. No significant effect of IL-1β treatment was observed 
on the overall dendritic morphology of neurons at P40 (Figure 5D), but there was a statistically 
significant shift in the number of dendrites showing a low frequency of spines, with 35% of the 
spines from Golgi stained cells from IL-1β treated animals showing a low spine frequency 
compared with 15% in saline treated tissue (p=0.007, Figure 5E, F). 
Discussion  
We have revealed a general decrease in the number of GABAergic interneurons in the cortex 
of preterm born human infants with diffuse white matter injury, compared with age-matched 
controls, and similarly in mice with diffuse white matter injury following IL-1β-induced 
inflammation. This interneuron deficit (reduced numbers and reduced morphological 
complexity) occurred in the absence of severe injury, as there were no changes in the numbers 
of neurons in the cortex in the clinical (human) or pre-clinical (mouse) study. Also, subtypes 
of interneurons were differentially affected over development indicating population specific 
vulnerabilities. The early disruption of interneuron populations in our clinical sample is 
supported by our pre-clinical evidence that not only did these changes persist but were found 
together with changes in the excitatory-inhibitory cell balance, spine density and the density 
of perineuronal nets. Altogether these data support the hypothesis that inflammation 
associated with preterm birth may alter the excitatory-inhibitory balance in the brain. This effect 
would partly explain the link between exposure to inflammation during development and poor 
neurodevelopmental outcomes in these infants that lead to life-long functional impairment. 
However, Canetta et al. (2016) have shown maternal immune activation at the very beginning 
of neurogenesis (E9 in the mouse) can also result in parvalbumin-specific pathology, possibly 
suggesting a particular susceptibility of this cell population to disturbances in normal 
development.  More work will be required to explore this concept. 
 
Interneurons are produced within the medial ganglionic eminence throughout development 
and migrate to all cortical layers (Butt et al. 2005, Butt et al. 2017). Interneuron fate is 
genetically coded, and follows a clear pattern of migration and maturation, related to the 
regulatory transcription factors imposed in the ganglionic eminence at the time of cell 
production (reviewed by Marin 2012; Kelsom & Lu, 2013). It is postulated that the 
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developmental period during which an injury or perturbation occurs will influence the cell 
population affected. Injury would also interact with genetic risks, which may affect when 
phenotypes caused by altered genetic code manifest, explaining the variety of 
neurodevelopmental disorders associated with similar phenotypes. Animal models allow the 
progression of injury to be assessed, in comparison with the snapshot of information typically 
obtained from clinical studies. The utility of the mice with IL-1β-induced inflammation and 
subsequent diffusion white matter injury used here, is that the injury is broadly comparable in 
nature to that seen in our patient samples. Specifically, this model displays the hallmarks of 
injury observed in contemporary preterm born infants; hypomyelination, axonopathy, 
oligodendrocyte dysmaturation and also, reported here and previously, no gross cortical injury 
evidenced by no change in cortical neuronal number (Favrais et al. 2011, Schang et al. 2014, 
Krishnan et al. 2017, Rangon et al. 2018). In this model, females have a less severe and more 
transient phenotype, which is why they were not used in this study (unpublished data), which 
suggests a bias seen in the animal model similar to that observed in the human population 
(Marlow et al. 2005). However, it is of course impossible to recapitulate the complex processes 
leading to injury in the human completely with any model and we would acknowledge that the 
differences in the magnitude of the observed changes probably lie in multifactorial injury to the 
infants. 
In this animal model, at the time when the brain is still being subjected to an inflammatory 
challenge (Krishnan et al. 2017) interneurons appear slightly increased in the cortex of injured 
animals compared with controls. It is worth noting that most interneuron populations are not 
properly established in the cortex at this stage (Cossart 2011), reflected in lower numbers than 
were found in the adult analysis. As development progresses, and after the injurious stimuli 
has resolved (at P10, Krishnan et al. 2017), a mild parvalbumin-specific neuronal reduction 
becomes apparent). Parvalbumin interneurons make up approximately 40% of GABAergic 
cortical interneurons, which, compared with the less frequent interneuron subpopulations, may 
make the detection of statistical changes in the cell population easier. Parvalbumin 
interneurons are fast-spiking interneurons with basket or chandelier morphology that make 
synaptic connections on proximal dendrites and the soma of target neurons (reviewed by 
(Marin 2012, Kelsom and Lu 2013). The cells produce oscillations in the gamma range (30-
80Hz) which is associated with cognitive processes such as memory and attention (Bartos et 
al. 2007, Canetta et al. 2016). This function may partly explain why parvalbumin knockout 
mice have an ASD-like phenotype: repetitive behaviours, impaired social interaction and 
communication, as well as reduced startle response and increase risk of seizure (Wohr et al. 
2015). 
 
The severity of injury will also have an effect on outcome, with more severe injury producing 
larger, more widespread changes. Previous studies of grey matter injury have been performed 
in human preterm infants with cystic white matter injury, in which there is extensive cell death 
and reactive gliosis. However, in our human post-mortem cases of diffuse white matter injury 
there was no overall change to neuronal number. Possibly unsurprisingly then, compared with 
our data of limited and cell type-specific changes, studies of grey matter injury in severe cystic 
cases show more widespread grey matter injury (Andiman et al. 2010, Kinney et al. 2012). As 
such, our data is an important contribution to understanding how interneuron deficits may 
impact on neurodevelopmental disorders for contemporaneous cohorts of preterm born 
infants. The diffuse white matter injury studied here is the predominant form of injury seen in 
preterm born infants, and cystic cases account for only approximately 5% of neuropathology, 
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based on MRI and ultrasound imaging studies in preterm cohorts (Hamrick et al. 2004; 
reviewed by Back, 2017).  
It must be noted that preterm birth occurs due to a complex, and often undetermined aetiology, 
and can be concomitant with other clinical findings, e.g. intrauterine growth restriction (IUGR), 
which in themselves are also predictive of reduced brain development (Rees et al. 2007; 
O’Shea et al. 2009; Korzeniewski et al. 2017). The fact that many infants in our cases (both 
WMI and non-WMI groups) have IUGR may well be a confounder in the injury observed. While 
the mouse data clearly links interneuron (and white matter) pathology with inflammation, it is 
likely that there are many contributing factors in preterm brain injury, of which inflammation is 
only one. This, and the different developmental timetables of mouse and human brains, may 
also explain the different interneuronopathies identified in this study. Adding to that complexity 
is the varying age range between the preterm white matter injury and non-white matter injury 
cohorts examined in this study. From a developmental point of view, the greater PMA of WMI 
group compared with control, should be associated with more visible interneurons in the cortex 
(through processes of migration and maturation). As a result, we suggest that the significant 
decrease in interneuron numbers in this group, is if anything, an underestimate of the 
interneuron injury in preterms with diffuse WMI. However, the longer survival times of these 
infants does increase the difficulty of defining the aetiology of the interneuron injury, as many 
features of the ex utero environment may contribute to the injury severity. For instance, Panda 
et al. (2018) suggest that deficits in maternal oestrogen is a major contributor to interneuron 
injury. That being said, in the data from the mouse model, when exposure to maternal 
oestrogen (and other factors of the external environment) is constant, there is still a reduction 
in interneurons.  
 
The significant early decreases seen for interneurons in general in this study, are similar to 
findings recently reported by Panda et al (2018), where early prematurity in humans was 
associated with a reduction in parvalbumin positive interneurons, primarily in the upper cortical 
layers, and an increase in somatostatin positive interneurons also in the upper cortex. There 
was also an overall decrease in glutamate decarboxylase (GAD)-positive neurons, attributed 
primarily to the changes in the parvalbumin subpopulation. However, a direct comparison with 
Panda and colleagues is difficult as their cases were compared based on the degree of 
prematurity rather than on their diagnosis (Panda et al. 2018). This resulted in a comparison 
of early born infants that had long survival times (up to 3-4 weeks) with later born preterm 
infants who had survival times of only 2-3 days. The role of postnatal care in interneuron 
development has been shown in a model of preterm delivery in the baboon, where 14 days of 
positive pressure ventilation lead a reduction in the numbers of calretinin positive cells in the 
visual cortex (Verney et al. 2010). Although this and other confounding factors are almost 
impossible to remove from a human post-mortem study, we are confident that our cases 
provide evidence more specifically related to the effects of prematurity on interneuron 
development without the specific effect of postnatal care. 
 
To further assess interneuron number, we investigated their migration through the subcortical 
white matter in our clinical cases. Reduced morphological complexity was observed for 
somatostatin and neuropeptide Y immunopositive neurons within the subcortical white matter 
in this study.  As these neurons are still migrating, changes in their morphology may reflect a 
disruption in migration that will contribute to later reduced interneurons in the cortex, another 
process associated with neurodevelopmental disorders (Marin 2013). It is possible that a delay 
in migration could explain initial reductions in interneuron number in the cortex that lessen or 
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normalise as development continues. Mild models of perinatal injury have recently shown 
altered neuronal arborisation in the sheep subplate (McClendon et al. 2017) and cortex (Dean 
et al. 2013), though these were not specific to interneurons. These changes in arborisation 
are generally interpreted as a delayed maturation, consistent with Diffusion Tensor Imaging 
data showing altered diffusion characteristics in the cortex of preterm infants (Ball et al. 2013). 
These most likely reflect reduced cortical complexity, and contribute to a delay in local 
connection formation (Batalle et al. 2019), which will have downstream effects on subsequent 
brain development. The mechanism of delayed maturation is, as yet, unclear, but could be 
due to delayed interneuron migration to the correct position within the cortex (as discussed 
above). Alternatively, this may be due to intrinsic changes that have occurred within the cells 
as a result of the injury, or due to a wider disruption of the network and integration of neurons 
within it. More work is required to elucidate this process. 
 
Perineuronal nets are a dynamic structure of extracellular matrix proteins that develop around 
a subpopulation of neurons in the brain. Parvalbumin interneurons are one of the cell types 
most commonly associated with perineuronal nets, and it has been suggested that these nets 
modulate the connections between cells, and the plasticity to form new connections (Shen 
2018). The presence of perineuronal nets around parvalbumin interneurons regulates Otx2 
levels, and critical periods of synaptic plasticity between these interneurons and their local 
networks (Beurdeley et al. 2012). It is unclear in many reports of parvalbumin neuronal loss in 
clinical cases or animal models of injury/neurodevelopmental disorders whether the deficit is 
actually in the number of parvalbumin interneurons, or in the expression of the parvalbumin 
protein within the neurons. In a SHANK3 knockout model of ASD a significant loss of 
parvalbumin staining was observed in the cortex, but no disruption in the perineuronal nets, 
implying presence of ‘parvalbumin-neurons’ but not of the parvalbumin protein (Filice et al. 
2016). This phenotype in both SHANK3 and parvalbumin knockout mice suggests loss of 
parvalbumin protein is associated with increased inhibition, whereas loss of the parvalbumin 
interneurons as a whole is associated with decreased inhibition (Wohr et al. 2015, Filice et al. 
2016).   
 
It should be noted that a number of models of hypoxic-ischemic perinatal injury have also 
shown changes in parvalbumin interneurons and, in some cases, their perineuronal nets. In 
the recent study by Fowke et al. (2018), a substantial loss of interneurons was observed in 
the cortex, and there was an associated disruption of the perineuronal nets within 7 days of 
the injury, particularly in layer 6 of the cortex. Loss of calbindin- and parvalbumin- 
immunopositive neurons from the striatum has also been reported after perinatal asphyxia 
(Van de Berg et al. 2003). However, as mentioned above, due to the much greater severity of 
this model of brain injury, compared with the inflammation-injury model used here, the 
mechanism of damage is likely to be quite different. In the context of severe damage, it is 
unclear how much the interneuron damage alone contributes to the neuropathology and 
behavioural deficits observed in cases of human hypoxic-ischemic encephalopathy.  
 
Early changes in calretinin-positive interneurons were also seen in this study, both in human 
and mouse tissue, however in mouse they didn’t persist after the initial injury period. Calretinin-
positive neurons are present in the cortex from as early as 12-weeks of gestation in the human 
brain (Al-Jaberi et al. 2015), possibly explaining their early response to injury. A reduction in 
calretinin-positive neurons was also observed in the visual cortex (but not other cortical 
regions) in a preterm baboon exposed to ventilator support (Verney et al. 2010), but not in the 
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caudate following prenatal cerebral ischemia in sheep (McClendon et al. 2014). However, it 
has recently been shown that there is a significant decrease in size and number of calretinin 
positive neurons in the caudate nucleus in the brains of autistic patients (Adorjan et al. 2017). 
A previous study of adult males with autism also showed a decrease in calretinin-positive 
interneurons specifically localised in the dentate gyrus of the hippocampus and more wide-
spread changes in parvalbumin-positive interneuron numbers (Lawrence et al. 2010). Of note, 
Canetta et al. (2016) clearly show no change in calretinin, or somatostatin, interneurons in 
their model of maternal immune activation induced brain injury. This suggests that calretinin 
and parvalbumin injury may occur via different mechanisms, or that early, mild changes in 
calretinin interneurons are normalised as development progresses. 
 
The altered frequency of synaptic boutons on the dendrites of Golgi stained neurons in the 
cortex was an interesting finding. Favuzzi et al. (2017) have shown that altering the integrity 
of perineuronal nets by the deletion of one component, in this case brevican, alters the 
electrophysical properties of interneurons, and subsequently the number of synapses of 
parvalbumin interneurons onto pyramidal neurons. While in the present study, there was not 
a significant loss of perineuronal nets at P40, the time when this altered synaptic distribution 
was observed, there was a small but significant decrease in the number of cells positive for 
both parvalbumin and perineuronal nets. This may suggest an on-going reduction in inhibitory 
control in the cortex, and a related change in the pyramidal neuron function. 
Electrophysiological studies will need to be performed to confirm if this is the case. However, 
it is important to note that long-term behavioural changes have been observed in this mouse 
model (Favrais et al. 2011) where animals treated with IL-1β from P1 to P5 fail to recognise 
novel or displaced objects in memory tests. Brevican deletion in the adult also showed 
impaired working and short-term memory (Favuzzi et al. 2017) supporting the assumption that 
the reduction in parvalbumin interneurons and perineuronal nets observed in this study may 
contribute to a disordered brain function.  
 
In conclusion, this study provides clinically important information on the effects of preterm birth 
to decrease parvalbumin neurons and their perineuronal nets, disrupt the excitatory-inhibitory 
cell balance and reduce spine density in the cortex. Altogether these suggest that a decrease 
in cortical inhibition may result from preterm birth and its associated exposures to inflammatory 
injuries, though the potential contribution of other factors in this complex clinical situation can’t 
be ruled out. The pathology can be consistently recognised from P10 in the mouse, 
approximately equivalent to term in humans. This suggests that it may be possible for 
pharmacological tools that modulate cortical excitability to correct the abnormal developmental 
trajectory of the brain. This would open therapeutic avenues for reducing the long-term burden 
of neurodevelopmental sequelae occurring in many millions of infants every year due to brain 
injury associated with preterm birth. 
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Table 1: Summary of clinical information of human post mortem cases 
Group Sex GA at 
birth 
(weeks) 
Postnatal 
age 
PMA at 
death 
(weeks) 
Clinical Context Neuropathology 
No White Matter Injury 
1 M 23+2 5min 23+2 Ass IUGR, 
oligohydramnios, 
congestive heart failure 
 
2 M 23+6 9h 51min 23+6 Ass IUGR (twin) leptomeninges 
congested with focal 
haemorrhages 
3 F 24+1 4h 40min 24+1 Extreme prematurity, 
congestive heart failure 
 
4 M 24+2 IUD/ 
Stillbirth 
24+2 Constricted umbilical 
cord, congestive heart 
failure 
 
5 M 25+3 21h 7min 25+3 Ass IUGR (twin) odematous brain with 
transtentorial herniation 
of the unci 
7 M 26+2 43h 26+3 TTT, 
Ass IUGR, 
pulmonary haemorrhage 
 
8 M 28+1 <1h 28+1 oligohydramnios, 
lung hypoplasia, 
congestive heart failure 
 
Non-Cystic White Matter Injury 
1 M 26+5 1d 7h 
52min 
26+6 Ass IUGR, 
oligohydramnios, 
congestive heart failure 
PVWM injury/pathology 
in PVWM at angles of 
the lateral ventricle 
2 M 24+6 16d 19h 
10min 
27+0 AAAFI, 
PPROM, 
acute necrotizing 
pneumonia 
PVWM injury/pathology 
in PVWM at angles of 
the lateral ventricle 
3 M 24+0 5w 1d 8h 
25min 
29+1 AAAFI, 
Retroplacental 
haemorrhage 
PVWM injury/pathology 
in PVWM at angles of 
the lateral ventricle 
4 M 29+3 11h 
17min 
29+3 TTT, 
AAAFI, 
Hydrops Fetalis 
GM/IVH 
5 M 27+5 12d 29+4 Ass IUGR, 
necrotizing entercolitis, 
uterine constraint/ 
oligohydramnios 
PVWM injury/pathology 
in PVWM at angles of 
the lateral ventricle 
6 M 26+0 1min 30+0 necrotizing enterocilitis Patchy WM gliosis 
Abbreviations: Asymmetric interauterine growth restriction (Ass IUGR), Acute ascending amniotic 
fluid infectin (AAAFI), germinal matrix (GM), intraventricular haemorrhage (IVH), preterm 
premature rupture of the membranes (PPROM), periventricular white matter (PVMW) Twin-Twin 
Transfusion (TTT), white matter (WM) 
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Figure legends 
 
Figure 1. Interneuron development in the cortex and subcortical white matter of the 
damaged preterm brain is altered compared with age-matched cases without white 
matter injury. Cell counts were performed in cortical and subcortical white matter in the frontal 
lobe, anterior to Ammon’s Horn. Total cortical neuronal number was assessed counting 
HuC/HuD positive neurons (A, C). A significant decrease in Calretinin (CalR)-positive 
interneurons was observed in the cortex of preterm brains with non-cystic white matter injury 
(WMI) compared with no WMI controls (B, D). No significant difference in Somatostatin (SST) 
or Neuropeptide Y (NPY)-positive interneurons was observed in the subcortical white matter. 
However, SST and NPY labelled interneurons from non-cystic white matter injury showed 
shorter neurites, with fewer branches (E, F). Data presented as mean ± SD; scale bar = 100µm 
(A-D), 25µm (E, G); * p<0.05, **p<0.01, ***p<0.001; Somatostatin (SST), Neuropeptide Y 
(NPY), white matter injury (WMI). 
 
Figure 2. P5 mice with inflammation-induced brain damage also show altered 
interneuron development across the cortex. Cortical development was assessed based on 
immunohistochemistry for general microstructure (DAPI), developing cortical neurons (CTIP2) 
and interneuron subpopulations at P5 (A, B). A significant decrease in Reelin and Calretinin 
(CalR)-positive neurons was observed in the whole cortex (C), but no change in CTIP2 positive 
pyramidal neurons (B). Assessment of the less prevalent interneuron populations according 
to upper (II-IV) or lower (V, VI) cortical layer distribution showed a small but significant increase 
the majority of interneuron populations in the lower layers (treatment effect, p=0.04, 2-way 
ANOVA) and no significant change in the upper layers (D, E). Data presented as mean ± SD; 
scale bar = 100µm. *p<0.05, ***p<0.001. Abbreviations: Calretinin (CalR), Parvalbumin (PV), 
Somatostatin (SST), Neuropeptide Y (NPY), Calbindin (CalB).  
 
Figure 3. Developmental pattern of interneuron injury changes by P10 in mice with 
inflammation-induced brain damage. Interneuron populations were assessed again at P10 
by immunohistochemistry (A) and quantified (B-E) for number and distribution through cortical 
layers. There was a significant decrease in the number of parvalbumin (PV)-positive 
interneurons across the cortex (B; treatment effect, p=0.01, 2-way ANOVA), but no change 
for somatostatin (SST), Neuropeptide Y (NPY), Calretinin (CalR) or Calbindin (CalB, C-F). 
Data presented as mean ± SD; scale bar = 100µm. *p<0.05. 
 
Figure 4. Long-term changes in parvalbumin positive interneurons and their 
perineuronal nets extend to P40 in mice with inflammation-induced brain damage. The 
beginning of perineuronal net formation could be seen in the cortex, primarily in layer IV, from 
as early as P10 (A, top row). The aggregation of the perineuronal nets and their association 
with the parvalbumin-positive interneurons became more pronounced through development 
(A, lower rows). In the IL-1β challenged mice, there was no gross alteration in perineuronal 
net formation or in the number of cortical parvalbumin neurons (B). However, there was a 
significant decrease in the number of PV+/PNN+ neurons in the upper layers of the cortex (C). 
Data presented as mean ± SD; scale bar = 100µm. *p<0.05. Abbreviations: Parvalbumin (PV), 
perineuronal nets (PNN). 
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Figure 5. By P40 the majority of interneuron pathology has recovered, but there are 
long-term changes in dendritic spines associated with the early inflammation-induced 
brain damage. No difference was seen in the number of Neuropeptide Y (NPY), Calretinin 
(CalR) or VIP-positive neurons (A-C) at P40. Golgi staining was performed to assess the 
general morphological development of cortical neurons at this stage. Image Ea is an example 
of a well stained cortical neuron used for spine analysis. Images Eb and c are representative 
images of spine density on dendrites in the brains of IL-1β and saline treated mice, 
respectively.  There was no significant difference in the dendritic arborisation (D) but there 
was a significant reduction in spine frequency on the dendritic processes in the IL-1β 
challenged mice (E, F). Data presented as mean ± SD; scale bar = 60µm for Da, 10µm for 
Db,c. **p<0.01. 
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